Introduction
Tumours of the larynx are rare and usually present with hoarseness of voice, cough or stridor. Although type 2 (hypercapnic) respiratory failure is a plausible late presentation of laryngeal tumours, very little published literature is available to support this theory. This case report describes a patient with a subglottic tumour who presented with uncompensated type 2 respiratory failure. It highlights the importance of clinical suspicion towards unexplained respiratory failure for achieving a prompt diagnosis and commencing adequate treatment.
Materials and methods
A 69-year-old man presented with a 6-week history of progressively worsening shortness of breath, which dramatically deteriorated over 2 days prior to hospital admission. The patient reported hoarseness of voice over the previous year, with no history of cough, wheeze, orthopnoea, muscular weakness or headache. His appetite had recently become poor, with no weight loss. His past medical history included hypertension, depression, osteoarthritis, right total knee replacement, left total hip replacement and right inguinal hernia repair. His current medications were amitriptyline, amlodipine, bendroflumethiazide, modified-release dihydrocodeine, paracetamol and ramipril. He had no allergies. His father had had a stroke in his 60s and his brother had died of a myocardial infarction at age 63 years. The patient was a retired warehouse worker and an ex-smoker of 2 weeks, with a 15 pack-year history of smoking. Before this episode, he was independent and active, and could walk for half a mile. However, for three weeks, his exercise capacity had been limited to 10 m.
On examination, he had inspiratory and expiratory stridor and was in respiratory distress, using accessory muscles. He had a respiratory rate of 24 breaths per minute and oxygen saturation of 95 per cent on 2 l of O2. On auscultation, breath sounds were present bilaterally; upper airway conducted noises were present. Cardiovascular examination showed a normal first and second heart sounds. His heart rate was regular with 106 beats per minute, his blood pressure was 120/70 mmHg, his jugular venous pressure was not elevated and there was no peripheral oedema. His abdomen was soft and non-tender, with normal bowel sounds; and there was no neurological deficit.
Blood test results were haemoglobin, 16.2 g/l; packed cell volume, 46 per cent; red blood cell count, 5.13 × 103/μl, platelet count, 196 × 103/μl; white blood cell count, 8.1 × 103/μl; C-reactive protein, 4 mg/l; and electrolyte and liver function tests, normal. Arterial blood gas analysis showed type 2 respiratory failure (results shown in Table I). Chest radiography showed clear lungs with no evidence of consolidation, oedema or pneumothorax. Electrocardiography showed left ventricular hypertrophy, with a sinus rhythm of 101 beats per minute.
Results of arterial blood gas analysis at admission and after biphasic positive airway pressure
*On 4 l/minute O2. †With inspiratory and expiratory positive airway pressure set at 12 and 4 cm H2O, respectively, 10 l/minute O2 and nebulisers. pH = the negative log of hydrogen ion concentration; pO2 = partial pressure of oxygen; pCO2 = partial pressure of carbon dioxide; BiPAP = biphasic positive airway pressure
Results
The patient was treated with salbutamol and ipratropium nebulisers and intravenous hydrocortisone, tazocin and fluids; treatment with biphasic positive airway pressure was started. A positive response to this treatment regimen was confirmed by a second arterial blood gas analysis (Table I). Intensive care physicians and ENT surgeons were involved in his care because of the stridor and to secure the airway. Flexible nasoendoscopy confirmed minimal abduction of the vocal folds, with a slightly oedematous epiglottis but no supraglottic mass. Despite initial improvements, the patient required urgent surgical tracheostomy and underwent definitive microlaryngoscopy, which showed a subglottic mass. Histological analysis confirmed the mass to be squamous cell carcinoma. Once stabilised, the patient underwent total laryngectomy and bilateral neck dissection to clear the disease; he made a slow recovery.
Discussion
Type 2 respiratory failure develops as a result of reduced minute ventilation relative to demand and increased dead space. This leads to decreased oxygen and increased carbon dioxide levels, which eventually cause respiratory acidosis.
The causes of type 2 respiratory failure include ventilation failure (e.g. chronic obstructive pulmonary disease), neuromuscular failure (e.g. myasthenia gravis), muscular failure (e.g. muscular dystrophy) and neurological failure (e.g. central hypoventilation or neuropathies). However, none of these seem to have been responsible for this patient's symptoms. There was no history of opiate treatment or of pre-existing neuromuscular disease or hypoventilation syndrome. The patient had normal inflammatory marker levels and there were no clinical findings consistent with infection (e.g. supraglottitis), which can cause airway obstruction if severe enough.Reference Kaynar and Sharma1 The patient had no documented airway disease, and blood gas analysis showed no evidence of hyperoxygenation; on arrival, he was breathing on air. He had no previous longstanding history of symptoms of cough, breathlessness, pedal oedema, wheeze or recurrent chest infection. Although he was a smoker of 15 pack-years, neither his history nor radiological findings (high-resolution computed tomography) indicated emphysematous changes. Although the patient was taking ramipril and bendroflumethiazide, epiglottic oedema was not severe enough to cause the obstruction.
In this patient, type 2 respiratory failure was most likely caused by airway narrowing secondary to a subglottic tumour. Though it was not possible to perform a spirometry as patient's condition did not allow for this to be performed neither when he was acutely unwell nor after he had tracheostomy, however as there was no evidence of emphysematous changes on HRCT chest, and his current symptoms did not suggest acute respiratory infection it is unlikely that his presention with respiratory failure was unlikely to be due to acute exacerbation of COPD. This has not been previously reported, and provides a useful reminder to both physicians and surgeons that upper airway obstruction is a possible aetiology for type 2 respiratory failure. The history of hoarse voice and breathlessness was consistent with laryngeal pathology. However, on admission the patient had only mild stridor, which was relieved by biphasic positive airway pressure. Furthermore, no masses were visible on flexible nasoendoscopy, making a diagnosis challenging. Therefore, the cause of respiratory failure could not be definitively identified until the patient underwent surgical tracheostomy and microlaryngoscopy.
• Subglottic tumours should be suspected in patients presenting with uncompensated type 2 respiratory failure
• Biphasic positive airway pressure is a safe therapy for patients with type 2 respiratory failure
Noninvasive positive pressure ventilation is an established treatment for type 2 respiratory failure secondary to chronic obstructive pulmonary disease and other airway diseases.Reference Plant, Owen and Elliott2 Essouri and colleagues’ physiological study demonstrated that noninvasive positive pressure ventilation improves the breathing pattern and reduces respiratory effort in patients with severe upper airway obstruction.Reference Essouri, Nicot, Clément, Garabedian, Roger and Lofaso3 Biphasic positive airway pressure reduces upper airway obstruction due to collapse during inspiration, and provides additional inspiratory pressure support which could contribute to greater unloading of the respiratory muscles. As a definite diagnosis had not been reached, biphasic positive airway pressure was considered the most appropriate treatment to improve blood oxygenation and correct the acid–base abnormality. This was used as a bridging measure while awaiting intensive care treatment, and provided sufficient time to arrange surgical tracheostomy. Helium–oxygen therapy is an established treatment for upper airway obstruction,Reference McGee, Wald and Hinchliffe4, Reference Smith and Biros5 but was unavailable. Hence, biphasic positive airway pressure, combined with intravenous steroids and nebulised adrenaline, was used.
Conclusion
This case report highlights the need for clinical suspicion towards subglottic tumours in patients presenting with type 2 respiratory failure. The positive outcome suggests that biphasic positive airway pressure is a potential bridging therapy for upper airway obstruction and seems to be safe and effective option a safe, option for patients in type 2 respiratory failure however further study is needed to support this observation.
